Long-term Monitoring & Adulthood
At a Glance
Long-term care for 3β-HSD deficiency involves adjusting hormone replacement as a person grows, checking growth, salt balance, hormone levels, bone health, and reproductive health, and preparing patients to manage stress dosing, emergency medication, fertility, and adult care.
Growing up with 3β-HSD deficiency requires a shift from the intensive focus of a new diagnosis to a long-term “health maintenance” mindset. Because this condition is so rare, your care team will use a combination of specialized blood tests and physical monitoring to ensure your child reaches their full potential for growth and development [1][2].
Routine Monitoring Through the Years
As your child grows, their medication needs will change. Regular visits to a pediatric endocrinologist—typically every 3 to 6 months—are essential for tracking their progress [3].
- Growth and Bone Age: At every visit, the doctor will map your child’s growth velocity (how fast they are growing). If growth is too fast or too slow, they may order a bone age X-ray of the hand to see if the skeleton is maturing too quickly [4].
- Hormone “Fingerprinting”: Because 3β-HSD is unique, standard CAH tests aren’t enough. Doctors monitor the “Δ5” family of hormones, specifically 17-hydroxypregnenolone and DHEA-S, using a precise method called LC-MS/MS [1][5].
- Cardiovascular Health: Regular blood pressure checks and monitoring of renin levels help ensure that the salt-balancing (mineralocorticoid) medication is at the right dose [6][7].
- Bone Density: In late adolescence or adulthood, your doctor may recommend a DEXA scan to check bone strength, especially if your child required higher doses of steroids during childhood [8].
Special Considerations for Males: TARTs
A specific concern for boys with all types of CAH is the development of Testicular Adrenal Rest Tumors (TARTs) [9]. These are benign (non-cancerous) growths made of adrenal-like tissue that can develop inside the testes.
- Why They Matter: If TARTs grow large, they can press on the healthy parts of the testes, potentially leading to gonadal failure or difficulty with fertility in adulthood [10][9].
- Screening: Evidence for TARTs in 3β-HSD deficiency comes mostly from case reports. While screening schedules are individualized, testicular ultrasounds may be recommended starting in adolescence, or earlier if clinical symptoms, poor hormonal control, or specialist concern arise [11][12].
- Prevention: Consistent, stable hormone replacement therapy may help prevent or shrink TARTs, though it is not a guarantee. Irregular medication use has been linked to tumor enlargement [13][9].
Special Considerations for Females: Hyperandrogenism and Cycles
For girls, the “backlog” of Δ5 hormones can affect the ovaries and menstrual health as they enter their teen years [10].
- Puberty: Most girls with 3β-HSD deficiency enter puberty spontaneously and on time [10]. However, it is common to see premature pubarche (early pubic hair) before the start of actual puberty [5].
- PCOS-like Symptoms: The high levels of adrenal androgens can lead to hyperandrogenism and PCOS-like symptoms (Polycystic Ovary Syndrome-like features), involving irregular periods, acne, and ovarian changes [5][6]. Note that true PCOS is diagnosed using specific criteria after excluding CAH, but these symptoms warrant specialized evaluation.
- Monitoring: Adolescent girls should be monitored for regular menstrual cycles. If cycles are absent or highly irregular, additional hormone support may be needed [1][10].
Adulthood, Fertility, and Transition
Living with 3β-HSD deficiency does not mean a person cannot have a family. While fertility can be more complex, many individuals have successful outcomes with the help of specialized care [10]. As a patient transitions from pediatric to adult endocrinology, they must learn to manage their stress dosing, renew emergency kits, and prepare for adult reproductive health.
- For Men: Fertility may be possible but requires specialized counseling and care. TARTs and gonadal dysfunction can impact sperm production. Some men may choose to pursue semen cryopreservation (sperm banking) in early adulthood as a precaution if TARTs are present [14]. There are documented cases of men with this condition achieving paternity [10][9].
- For Women: Fertility may be possible, though it may require “fine-tuning” of medication to ensure regular ovulation [10][15]. Pregnant individuals with CAH require very careful stress dosing plans for labor and delivery [16].
- Genetic Counseling: Before starting a family, preconception genetic counseling is recommended to discuss carrier risks for partners [1].
- The Goal of Suppression: It is important to remember that the goal is not to “zero out” every hormone. In 3β-HSD, trying to force Δ5 hormones into a “normal” range with very high doses of steroids often leads to more side effects rather than better health outcomes [3].
Surveillance Summary Table
| Age Group | Focus Area | Common Tools |
|---|---|---|
| Infancy/Childhood | Growth & Salt Balance | Height, Weight, Renin, Electrolytes [17] |
| Early Childhood+ | Bone Maturity | Bone Age X-ray (as needed) [4] |
| Childhood/Puberty | Testicular Health (Males) | Routine Physical Exams & Ultrasound (Individualized) [12] |
| Adolescence | Pubertal Progression | Tanner Staging, Menstrual History [10] |
| Adulthood | Metabolic & Bone Health | Blood Pressure, DEXA Scan, Fertility Review [8] |
Common questions in this guide
How often should a child with 3β-HSD deficiency see an endocrinologist?
Which hormone tests help monitor 3β-HSD deficiency?
When might a boy need screening for TARTs?
How can 3β-HSD deficiency affect puberty and menstrual cycles?
Can people with 3β-HSD deficiency have children?
What should be included when transitioning from pediatric to adult care?
One line in your results can change your plan.
Growth velocity that is too fast or too slow may lead your clinician to order a bone age X-ray. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency.
Al Alawi AM, Nordenström A, Falhammar H
Endocrine 2019; (63(3)):407-421 doi:10.1007/s12020-018-01835-3.
PMID: 30719691 - 2
Rare forms of congenital adrenal hyperplasia.
Gurpinar Tosun B, Guran T
Clinical endocrinology 2024; (101(4)):371-385 doi:10.1111/cen.15009.
PMID: 38126084 - 3
Severe Salt-Losing 3β-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G>A Homozygotes.
Benkert AR, Young M, Robinson D, et al.
The Journal of clinical endocrinology and metabolism 2015; (100(8)):E1105-15 doi:10.1210/jc.2015-2098.
PMID: 26079780 - 4
Late diagnosis of 3β-Hydroxysteroid dehydrogenase deficiency: the pivotal role of gas chromatography-mass spectrometry urinary steroid metabolome analysis and a novel homozygous nonsense mutation in the HSD3B2 gene.
Fanis P, Neocleous V, Kosta K, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(1)):131-136 doi:10.1515/jpem-2020-0245.
PMID: 33180036 - 5
Revisiting Classical 3β-hydroxysteroid Dehydrogenase 2 Deficiency: Lessons from 31 Pediatric Cases.
Guran T, Kara C, Yildiz M, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgaa022.
PMID: 31950145 - 6
Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria.
Ladjouze A, Donaldson M, Plotton I, et al.
Frontiers in endocrinology 2022; (13()):867073 doi:10.3389/fendo.2022.867073.
PMID: 35757411 - 7
A New Homozygous Frameshift Mutation in the HSD3B2 Gene in an Apparently Nonconsanguineous Italian Family.
Bizzarri C, Massimi A, Federici L, et al.
Hormone research in paediatrics 2016; (86(1)):53-61 doi:10.1159/000444712.
PMID: 27082427 - 8
Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency.
Auer MK, Paizoni L, Hofbauer LC, et al.
The Journal of steroid biochemistry and molecular biology 2020; (204()):105734 doi:10.1016/j.jsbmb.2020.105734.
PMID: 32784048 - 9
Extensive Bilateral Adrenal Rest Testicular Tumors in a Patient With 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency.
Lolis E, Juhlin CC, Nordenström A, Falhammar H
Journal of the Endocrine Society 2018; (2(6)):513-517 doi:10.1210/js.2018-00082.
PMID: 29850650 - 10
3β-Hydroxysteroid dehydrogenase type-2 deficiency: Our experience and gonadal function-focused systematic review.
Daga A, Phadte A, Karlekar M, et al.
Endocrine 2026; (91(1)).
PMID: 41920275 - 11
Testicular adrenal rest tumors in children with congenital adrenal hyperplasia.
Al-Ghamdi WM, Shazly MA, Al-Agha AE
Saudi medical journal 2021; (42(9)):986-993 doi:10.15537/smj.2021.42.9.20210257.
PMID: 34470837 - 12
Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors.
Vaid S, Kulkarni S, Marko J, et al.
The Journal of clinical endocrinology and metabolism 2026; (111(3)):698-706 doi:10.1210/clinem/dgaf498.
PMID: 40921717 - 13
Case Report:clinical experience of bilateral giant pediatric Testicular adrenal rest tumors with 3 Beta-Hydroxysteroid Dehydrogenase-2 family history.
Yu L, Chen P, Zhu W, et al.
BMC pediatrics 2021; (21(1)):405 doi:10.1186/s12887-021-02883-x.
PMID: 34526000 - 14
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia.
Claahsen-van der Grinten HL, Stikkelbroeck N, Falhammar H, Reisch N
European journal of endocrinology 2021; (184(3)):R85-R97.
PMID: 33320831 - 15
Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Engberg H, Nordenström A, Hirschberg AL
The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S37-S45 doi:10.1210/clinem/dgae696.
PMID: 39836618 - 16
Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK.
Woodcock T, Barker P, Daniel S, et al.
Anaesthesia 2020; (75(5)):654-663 doi:10.1111/anae.14963.
PMID: 32017012 - 17
Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
Neumann U, van der Linde A, Krone RE, et al.
European journal of endocrinology 2022; (186(5)):587-596 doi:10.1530/EJE-21-1085.
PMID: 35290211
This page is for informational purposes only and does not constitute medical advice. Your endocrinology team should personalize testing, medication, emergency planning, and fertility care for your situation.